Manufacturing of various types of autoinjectors, most of which are disposable systems that use prefilled syringes as primary drug containers.

Health & Fitness / Analysis, Biotech, market, Pharma, Research / By /

In addition to enabling patients to self-medicate, these devices are designed to ensure safety during the dosing process and promote compliance to prescribed therapeutic regimens. Moreover, the adoption of autoinjectors, and other self-injection products, has enabled significant cost savings for end users by eliminating the need to visit hospitals / out-patient clinics for dosing.

Advertisements

 

To order this 600+ page report, which features 360+ figures and 350+ tables, please visit this link

A competitiveness analysis of various disposable and reusable autoinjectors, taking into consideration supplier power (based on year of establishment and company size) and key product specifications, such as route of administration, primary drug container used, injector actuation mechanism, type of dose and user friendliness of the product.

An in-depth analysis of the various patents that have been filed / granted related to autoinjectors, till August 2019, highlighting details on key parameters, such as type of patent, publication year, issuing authority, CPC classification, emerging focus areas and leading industry players (on the basis of number of patents). It also includes a detailed patent benchmarking and an insightful valuation analysis.

The USD 2.5 billion (by 2030) financial opportunity within the global autoinjectors market has been analyzed across the following segments:

  • Usability
  • Disposable
  • Reusable
  • Route of administration
  • Subcutaneous
  • Intramuscular
  • Type of molecule
  • Antibody
  • Peptide
  • Protein
  • Small molecule
  • Therapeutic indication
  • Anaphylaxis
  • Diabetes
  • Migraine
  • Multiple sclerosis
  • Rheumatoid arthritis
  • Other indications
  • Key geographical regions
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

The Global Autoinjectors Market (3rd Edition), 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • Antares Pharma
  • Consort Medical (Previously Bespak)
  • DALI Medical Devices
  • Elcam Medical (E3D Elcam Drug Delivery Devices)
  • Jiangsu Delfu Medical Devices
  • Oval Medical Technologies
  • Owen Mumford
  • SHL Group
  • Union Medico®
  • Ypsomed

 

Table of Contents

 

  1. Preface

    2. Executive Summary

  2. Introduction
  3. Primary Drug Containers
  4. Autoinjectors: Current Market Landscape
  5. Product Competitiveness Analysis
  6. Brand Positioning of Key Industry Players
  7. Patent Analysis
  8. Therapeutic Products Available in Autoinjectors
  9. Case Study: Autoinjector-based Combination Products and Affiliated Therapeutic Areas
  10. Likely Drug Candidates for Delivery Via Autoinjectors
  11. Key Players
  12. Emerging Players
  13. KOL Analysis
  14. SWOT Analysis
  15. Case Study: Medical Device Contract Service Providers
  16. Market Sizing and Opportunity Analysis
  1. Conclusion
  1. Interview Transcripts
  1. Appendix 1: Tabulated Data
  1. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 

Related Posts